Table: Peptidream -Q1 parent results
Nov 8 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Sep 30, 2016 Sep 30, 2015 Jun 30, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 796 mln 389 mln
(+104.6 pct) (+175.4 pct)
Operating 380 mln 75 mln
(+403.9 pct)
Recurring 398 mln 57 mln
(+588.0 pct)
Net 279 mln 37 mln
(+643.7 pct)
EPS 4.91 yen 0.68 yen
EPS Diluted 4.30 yen 0.58 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner